Physician profile
Sydney Hiserodt
NPI 1730955568
$357.99
in general payments reported to CMS, 2019-2025
10 companies · $358 in 2025
The $358 reported for 2025 was more than what 79% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $107.64 | 2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $55.28 | 2025 | |
| Hologic Sales and Service, LLC | $44.94 | 2025 | Aptima |
| Sage Therapeutics, LLC | $34.07 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $30.66 | 2025 | Slynd |
| Exact Sciences Corporation | $20.53 | 2025 | The Cologuard Plus Collection Kit |
| Shield Therapeutics INC | $19.40 | 2025 | |
| Millicent US INC | $16.47 | 2025 | Intrarosa, Femring |
| Evofem Biosciences, INC. | $14.57 | 2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $14.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydney Hiserodt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.